12-110911157-C-T

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate

The NM_000432.4(MYL2):​c.421G>A​(p.Ala141Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 31)

Consequence

MYL2
NM_000432.4 missense

Scores

3
10
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 7.53
Variant links:
Genes affected
MYL2 (HGNC:7583): (myosin light chain 2) This gene encodes a major sarcomeric protein in mammalian striated muscle. The encoded protein plays a role in embryonic heart muscle structure and function, while phosphorylation of the encoded protein is involved in cardiac myosin cycling kinetics, torsion and function in adults. Mutations in this gene are associated with hypertrophic cardiomyopathy 10 and infant-onset myopathy. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM1
In a chain Myosin regulatory light chain 2, ventricular/cardiac muscle isoform (size 164) in uniprot entity MLRV_HUMAN there are 33 pathogenic changes around while only 3 benign (92%) in NM_000432.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.849

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYL2NM_000432.4 linkc.421G>A p.Ala141Thr missense_variant Exon 7 of 7 ENST00000228841.15 NP_000423.2 P10916Q6IB42
MYL2NM_001406745.1 linkc.379G>A p.Ala127Thr missense_variant Exon 6 of 6 NP_001393674.1
MYL2NM_001406916.1 linkc.364G>A p.Ala122Thr missense_variant Exon 7 of 7 NP_001393845.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYL2ENST00000228841.15 linkc.421G>A p.Ala141Thr missense_variant Exon 7 of 7 1 NM_000432.4 ENSP00000228841.8 P10916
MYL2ENST00000548438.1 linkc.379G>A p.Ala127Thr missense_variant Exon 6 of 6 3 ENSP00000447154.1 G3V1V8
MYL2ENST00000663220.1 linkc.364G>A p.Ala122Thr missense_variant Exon 7 of 7 ENSP00000499568.1 A0A590UJU8

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypertrophic cardiomyopathy 10 Uncertain:2
Feb 01, 2018
Institute of Human Genetics, University of Leipzig Medical Center
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 141 of the MYL2 protein (p.Ala141Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of MYL2-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 178948). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Uncertain:1
May 03, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The Ala141Thr variant in MYL2 has not been reported in individuals with cardiomy opathy or in large population studies. Alanine (Ala) at position 141 is conserv ed across evolutionarily distinct species, increasing the likelihood that this c hange would not be tolerated. Other computational analyses (biochemical amino a cid properties, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support fo r or against an impact to the protein. Additional information is needed to full y assess the clinical significance of the Ala141Thr variant. -

not provided Uncertain:1
May 29, 2024
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30706179) -

Primary dilated cardiomyopathy Uncertain:1
May 08, 2019
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
CardioboostCm
Benign
0.066
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Uncertain
0.020
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
T;.
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.92
D;D
M_CAP
Pathogenic
0.57
D
MetaRNN
Pathogenic
0.85
D;D
MetaSVM
Uncertain
-0.14
T
MutationAssessor
Uncertain
2.6
M;.
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.6
N;N
REVEL
Uncertain
0.52
Sift
Benign
0.41
T;T
Sift4G
Benign
0.58
T;T
Polyphen
0.85
P;.
Vest4
0.79
MutPred
0.51
Gain of catalytic residue at P143 (P = 0.0028);.;
MVP
0.91
MPC
1.0
ClinPred
0.97
D
GERP RS
5.0
Varity_R
0.37
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs727504559; hg19: chr12-111348961; COSMIC: COSV57407889; COSMIC: COSV57407889; API